IP Library Granted Patent US 7,888,304
Granted Patent B2
US 7,888,304 · App. 11/831,552 · Granted Feb 15, 2011

Use of carrageenan in an enzyme flush

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,888,304
App. No.
11/831,552
Granted
Feb 15, 2011
Kind
B2
Abstract

The present disclosure is directed to methods and compositions for clearing and cleaning enteral feeding tubes. More particularly, the composition is an ingestible gel composition that comprises enzymes for degrading buildup in enteral feeding tubes, carrageenan, and divalent metal ions or a source thereof. The carrageenan present in the composition stabilizes the enzymes at room temperatures, allowing for long-term storage of the composition. Upon injecting the gelled composition into the feeding tube, body heat from the patient melts the gel, and the enzymes are released to act on debris present in the feeding tube.

Claims (17)

1. A method of clearing and cleaning the lumen of a feeding tube, the method comprising injecting an ingestible gel composition into the feeding tube, the ingestible gel composition comprising iota carrageenan, a divalent metal ion or source thereof, and from about 20% (w/v) to about 40% (w/v) of an enzyme for degrading buildup in the tube, wherein the composition has a viscosity of at least about 9,000 centipoise at room temperature, and a viscosity of about 4,000 or less at body temperature.

2. The method of claim 1 wherein the composition comprises from about 0.5% (w/v) to about 2.0% (w/v) carrageenan.

3. The method of claim 1 wherein the divalent metal ion is selected from the group consisting of calcium, magnesium, beryllium, strontium, barium, and combinations thereof.

4. The method of claim 3 wherein the divalent metal ion is a calcium ion.

5. The method of claim 1 wherein the composition comprises from about 0.01% (w/v) to about 1.0% (w/v) of the divalent metal ion.

6. The method of claim 1 wherein the enzyme is selected from the group consisting of protease, lipase, cellulase, amylase, and combinations thereof.

7. The method of claim 1 wherein the enzyme is selected from the group consisting of papain, lipase, cellulase, and combinations thereof.

8. The method of claim 7 wherein the composition comprises about 40% (w/v) of papain at 600,000 TU/g.

9. The method of claim 7 wherein the composition comprises about 40% (w/v) of lipase at 200,000 FIP/g.

10. The method of claim 7 wherein the composition comprises about 20% (w/v) of cellulase at 150,000 CU/g.

11. The method of claim 1 wherein the enzymes degrade protein, starch, cellulose, lipids, and combinations thereof present in the lumen of the tube.

12. The method of claim 1 wherein the composition further comprises from about 5% (w/v) to about 40% (w/v) water.

13. The method of claim 1 wherein the composition has a pH of from about 3 to about 7.

14. A method of clearing and cleaning the lumen of a feeding tube, the method comprising injecting an ingestible gel composition into the feeding tube, the ingestible gel composition comprising from about 0.5% (w/v) to about 2.0% (w/v) of iota carrageenan, from about 0.01% (w/v) to about 1.0% (w/v) of a divalent metal ion or source thereof, and from about from about 20% (w/v) to about 40% (w/v) of an enzyme for degrading buildup in the tube.

15. The method of claim 14 wherein the composition has a viscosity of at least about 9,000 centipoise at room temperature, and a viscosity of about 4,000 or less at body temperature.

16. The method of claim 15 wherein the divalent metal ion is a calcium ion.

17. The method of claim 16 wherein the composition comprises about 0.015% (w/v) of calcium ion and about 1.0% (w/v) iota carrageenan.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
SECURITY INTEREST Recorded Jun 24, 2022
From: AVENT, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060441/0445 →
INTELLECTUAL PROPERTY SECURITY INTEREST ASSIGNMENT AGREEMENT Recorded Jan 23, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: CITIBANK, N.A.
Reel/Frame 048173/0137 →
SECURITY INTEREST Recorded Apr 6, 2015
From: AVENT, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035375/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034753/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2008
From: CARNEY, SARA A.; KOENIG, DAVID WILLIAM; BEGAWALA, JUNAID
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 020439/0541 →